BFC Planning’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-5
Closed -$18 – 2676
2024
Q3
$18 Buy
+5
New +$19 ﹤0.01% 2582

Other funds holding PALI

BFC Planning's PALI Position: Q4 2024 in Review

BFC Planning sold out of Palisade Bio (PALI) in Q4 2024, closing a stake of 5 shares — an estimated $18 sold.

BFC Planning first reported a position in PALI in Q3 2024 and held it in 1 quarter. The position peaked at $18 in Q3 2024. 10 funds tracked by Wall St. Rank hold PALI as of Q4 2024.

  • BFC Planning reported no remaining Palisade Bio position as of Q4 2024 after selling out during the quarter.
  • BFC Planning sold 5 Palisade Bio shares in Q4 2024, an estimated $18.
  • BFC Planning first reported a position in Palisade Bio in Q3 2024 and held it in 1 quarter.
  • BFC Planning's Palisade Bio position peaked at $18 in Q3 2024.
  • 10 funds tracked by Wall St. Rank held Palisade Bio as of Q4 2024.

Based on BFC Planning's 13F filing for Q4 2024, filed 29 Oct 2026.